{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T17:55:57Z","timestamp":1774115757173,"version":"3.50.1"},"reference-count":12,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2019,11,30]]},"DOI":"10.1536\/ihj.19-134","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T18:04:12Z","timestamp":1572458652000},"page":"1441-1443","source":"Crossref","is-referenced-by-count":8,"title":["Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant"],"prefix":"10.1536","volume":"60","author":[{"given":"Takeshi","family":"Nehashi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Oikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Amami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Misaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kunii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Nakazato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tanskanen M, Peuralinna T, Polvikoski T, <i>et al<\/i>. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 2008; 40: 232-9.","DOI":"10.1080\/07853890701842988"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tasaki M, Ueda M, Obayashi K, <i>et al<\/i>. Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach. Int J Cardiol 2013; 170: 69-74.","DOI":"10.1016\/j.ijcard.2013.10.033"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sawada N, Nakayama A, Takahashi M, <i>et al<\/i>. Correct diagnosis of wild-type transthyretin-related amyloidosis followed by the introduction of a novel therapy in a patient with cardiac wall thickening of unknown cause. Int Heart J 2017; 58: 147-50.","DOI":"10.1536\/ihj.16-224"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G, <i>et al<\/i>. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015; 36: 2585-94.","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Casta\u00f1o A, Narotsky DL, Hamid N, <i>et al<\/i>. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 2017; 38: 2879-87.","DOI":"10.1093\/eurheartj\/ehx350"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener 2014; 3: 19.","DOI":"10.1186\/2047-9158-3-19"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yoshinaga T, Yazaki M, Ohno M, Kodama S, Koyama J, Sekijima Y. Cardiac Amyloidosis associated with amyloidogenic transthyretin V122I variant in an elderly Japanese woman. Circ J 2017; 81: 893-4.","DOI":"10.1253\/circj.CJ-16-1202"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Jacobson DR, Pastore RD, Yaghoubian R, <i>et al<\/i>. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in Black Americans. N Engl J Med 1997; 336: 466-73.","DOI":"10.1056\/NEJM199702133360703"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hamour IM, Lachmann HJ, Goodman HJ, <i>et al<\/i>. Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis. Am J Transplant 2008; 8: 1056-9.","DOI":"10.1111\/j.1600-6143.2008.02162.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamashita T, Hamidi Asl K, Yazaki M, Benson MD. A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 2005; 12: 127-30.","DOI":"10.1080\/13506120500107162"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Quarta CC, Buxbaum JN, Shah AM, <i>et al<\/i>. The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans. N Engl J Med 2015; 372: 21-9.","DOI":"10.1056\/NEJMoa1404852"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Maurer MS, Schwartz JH, Gundapaneni B, <i>et al<\/i>. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 2018; 379: 1007-16.","DOI":"10.1056\/NEJMoa1805689"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/6\/60_19-134\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T06:58:30Z","timestamp":1575269910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/60\/6\/60_19-134\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-134","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,30]]}}}